Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178672 · ClinicalTrials.gov registry record · Phase 4
A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
NCT00178672 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 69 participants.
The verdict
NCT00178672, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety and effectiveness of stenting in the treatment of obstructive carotid artery disease. Secondary objectives are the assessment and standardization of optimal operator techniques and successful deployment and retrieval of the AngioGuard XP Distal Protection Device. This is a single center, prospective, open-label feasibility study. The study population will consist of patients with atherosclerotic obstructive or post-endarterectomy restenotic lesions in native carotid arteries. The intention is to include patients with both types of lesions.
Interventions
- DEVICE Angioguard XP distal protection device
- PROCEDURE Heart Catheterization -Angioplasty
- DEVICE stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2002-11 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178672
The ClinicalTrials.gov registry entry for NCT00178672 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Angioguard XP distal protection device is the first listed.
NCT00178672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178672 about?
NCT00178672 is a clinical study titled "A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease". The primary objective of this study is to assess the safety and effectiveness of stenting in the treatment of obstructive carotid artery disease. Secondary objectives are the assessment and standardization of optimal operator techniques and successful deployment and retrieval of the AngioGuard XP Di...
What is the current status of trial NCT00178672?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2002-11. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00178672?
The interventions under investigation include: Angioguard XP distal protection device (DEVICE), Heart Catheterization -Angioplasty (PROCEDURE), stenting (DEVICE).
Who is sponsoring clinical trial NCT00178672?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.